Core Points - Picard Medical, Inc. successfully closed its initial public offering (IPO) of 4,250,000 shares at a price of $4.00 per share, generating gross proceeds of $17 million before deductions [1] - The company has granted underwriters an option to purchase an additional 637,500 shares to cover over-allotments within 30 days of the offering [1] - The shares began trading on the NYSE American under the ticker symbol "PMI" on August 29, 2025 [1] Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is recognized as the leader in total artificial heart technology for patients with end-stage heart failure [5] - The SynCardia Total Artificial Heart (STAH) is the only commercially available artificial heart approved by both the FDA and Health Canada, with over 2,100 implants performed across 27 countries [5] - The STAH is noted for being the most widely used and extensively studied artificial heart globally [5]
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
Globenewswire·2025-09-02 20:05